Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
Pfizer reported a strong fourth quarter (Q4) of 2024, achieving $17.8 billion in total revenues, reflecting a 21% year-o...
Bowtie, Hong Kong’s first virtual insurer, has collaborated with Gleneagles Hospital Hong Kong and Pfizer Hong Kon...
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...
China-based Zai Lab and American pharmaceutical firm Pfizer have announced a strategic collaboration for the novel anti-...
Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...
Pfizer Singapore organized a media roundtable to advocate for greater awareness on respiratory diseases and introduce th...
Australia is stepping up to the global fight against antimicrobial resistance, as Pfizer Australia announces a major upg...
Pfizer Inc. unveiled its new highly automated Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
